
Prestige Brands Holdings Inc
Prestige Brands Holdings, Inc. (PBH) is a USโbased owner and marketer of branded overโtheโcounter healthcare, household and personalโcare products. With a market capitalisation of about $3.08 billion, the company grows by supporting established consumer brands across pharmacy, grocery and online channels, combining marketing, distribution and selective acquisitions. Investors should note the business is cashโgenerative but historically operates with meaningful leverage from past buyโandโbuild activity, which can make earnings sensitive to interest rates and refinancing cycles. Key potential positives include steady demand for staple healthcare items, brand pricing power and opportunities in eโcommerce and international expansion. Key risks include competition, changing retailer dynamics, inputโcost inflation and the possibility that acquisitions fail to meet expectations. This summary is educational and not personalised investment advice; stock values can rise or fall and past performance is not a guide to the future. Consider your risk tolerance and time horizon before deciding whether this stock fits your portfolio.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Prestige Brands stock, expecting its price to rise significantly.
Financial Health
Prestige Brands is performing well with strong revenue and cash flow, indicating solid financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring PBH
Walgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: September 2, 2025
Explore BasketWalgreens' Restructuring: A New Healthcare Landscape
Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
Published: August 29, 2025
Explore BasketThe Resilient Premium Consumer
This carefully selected group of stocks focuses on companies catering to affluent consumers who continue spending despite economic uncertainty. Based on American Express's record revenue from premium cardholders, these professional-picked investments target the luxury segment's enduring strength.
Published: July 21, 2025
Explore BasketSmart Shopper Portfolio
Invest in brands you already know and trust that stock your shelves at home. These aren't just familiar namesโthey're companies that financial experts have given their strongest vote of confidence with "Strong Buy" ratings.
Published: June 17, 2025
Explore BasketWhy Youโll Want to Watch This Stock
Steady brand demand
Established OTC and household brands often sustain consistent sales; however, performance can vary with retail trends and competition.
Acquisition strategy focus
Management has used acquisitions to add scale and new products, which can boost growth but may raise leverage and execution risk.
Retail and eโcommerce mix
Sales rely on pharmacies, supermarkets and online channels, offering diversification yet exposing the business to changing retailer dynamics.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
Amgen Inc.
Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.
ADMA BIOLOGICS INC
Develops products to treat immune deficiencies and chronic diseases.